Last update:
HIV & AIDS news
HIV & AIDS
Preventive care may no longer be free in 2026 because of HIV stigma
Many Americans were relieved when the Supreme Court left the Affordable Care Act in place following the law's third major legal challenge in June 2021. This decision permitted widely supported policies to continue, such as ...
Apr 15, 2025
0
0
HIV & AIDS
Worm eradication: A surprising ally in the fight against HIV
Researchers from the Munich Tropical Institute, the Tanzanian NIMR-MMRC, DZIF, together with colleagues from Bonn, have discovered a risk factor for HIV infection that has received little attention to date. In an earlier ...
Apr 10, 2025
0
38
Key HIV care teams let go, putting mothers and children at risk
The Trump administration has let go of the last remaining U.S. health officials who oversaw HIV care for more than 1.1 million mothers and children in low-income countries.
Apr 9, 2025
0
0
HIV prevention medicines could soon be over-the-counter in Georgia
Georgia lawmakers are hoping to pass a bill before the legislative session ends Friday that would allow pharmacists to distribute HIV prevention medicines without a prescription, a policy change that would allow quicker access ...
Apr 7, 2025
0
0
Molecular stool test could improve detection of tuberculosis in adults with HIV
The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be established as an additional test for diagnosing tuberculosis in adults living with HIV.
Apr 4, 2025
0
11
Novel point-of-care technology delivers accurate HIV results in minutes
A team of Northwestern University scientists spanning disciplines have developed new technology that could lead to the creation of a rapid point-of-care test for HIV infection competitive with traditional lab-based HIV testing ...
Apr 2, 2025
0
41
Foreign aid cuts could mean 10 million more HIV infections by 2030—and almost 3 million extra deaths
In January, the Trump administration ordered a broad pause on all US funding for foreign aid.
Mar 29, 2025
0
0
Gender-affirming care may reduce the risk of HIV among trans, nonbinary and gender-diverse people
Gender-affirming hormone therapy (GAHT) is associated with significantly improved HIV outcomes for transgender, nonbinary, and other gender-diverse (trans) people in the U.S., according to a new study published in The Lancet ...
Mar 28, 2025
1
53
Clinical trials show new antibody therapy offers long-lasting HIV control without daily medication
If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in controlling the virus, no treatment can yet completely eradicate HIV once it has taken hold. But promising ...
Mar 28, 2025
0
0
Cuts to foreign aid could result in millions of HIV deaths and soaring rates of global infections, modeling study finds
A new modeling study published in The Lancet HIV journal highlights the alarming potential impact of significant reductions in international funding for HIV prevention and treatment programs.
Mar 26, 2025
7
24
AIDS pandemic risks 'resurging globally' amid US funding halt: UN
The world risks returning to the worst days of the global AIDS pandemic following the sudden halt to US foreign aid funding, the UN's top AIDS official said Monday, warning millions would die.
Mar 24, 2025
0
0
Simulation model shows potential affordability of preventive HIV therapy for infants
HIV infections are lifelong and can weaken the immune system, causing a patient to be more susceptible to infection and various cancers. Children of mothers with HIV are at risk of developing an HIV infection as it is transmittable ...
Mar 20, 2025
0
0
Trump administration may cut CDC's HIV prevention division
The Trump administration is weighing elimination of the U.S. Centers for Disease Control and Prevention's (CDC) Division on HIV Prevention, sparking concerns among public health experts.
Mar 20, 2025
0
0
Single vaccine dose shows 84% effectiveness against mpox, but insufficient for HIV patients
Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient ...
Mar 19, 2025
0
0
Study shows significant progress in HIV treatment initiation in the Asia-Pacific region
In a study published in AIDS Research and Therapy, Ph.D. candidate Thinh Vu explores the temporal trends in the time from HIV diagnosis to the initiation of antiretroviral therapy (ART) across the Asia-Pacific region. This ...
Mar 19, 2025
0
0
Machine learning could help predict adherence to HIV treatment in adolescents
Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million people in the world living with HIV. Although the government in Uganda provides antiretroviral treatment ...
Mar 17, 2025
0
0
HIV doctors urge US to reverse 'catastrophic' funding cuts
Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, saying they are "doing catastrophic harm" to the global fight against AIDS.
Mar 15, 2025
0
2
Researchers develop method to identify dormant cells that carry HIV
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure for the infection affecting ...
Mar 13, 2025
0
15
HIV's latent reservoir: New insights into Nef protein offer potential strategy to improve treatment
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human immunodeficiency virus (HIV) hides dormant inside of cells shrinks when treated.
Mar 13, 2025
0
7
Reformulation of HIV prevention drug lenacapavir makes it last for a year
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV prevention drug lenacapavir allows it to persist in the body for up to a year. In their paper published ...
Study highlights gaps in HPV-related cancer prevention for people living with HIV
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.
Mar 12, 2025
0
0
Study examines a novel way to bring addiction care and HIV prevention to people who inject drugs
Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.
Mar 12, 2025
0
0
People with HIV in Malawi face greater risk for dementia
Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according to a new study by a team of US and Malawian researchers.
Mar 12, 2025
0
0
Immune response may be harnessed to control HIV, primary trial results suggest
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by immune-based therapies.
Mar 11, 2025
0
0
Trump is cancelling a republican project to wipe out AIDS, putting millions of lives at risk
Enormous progress has been made in tackling the global HIV epidemics over the past two decades. The number of people dying from HIV-related causes has fallen by 51% since 2010; and the number of annual new infections has ...
Mar 11, 2025
0
0
